Nixon Peabody Trust CO Renovo Rx, Inc. Transaction History
Nixon Peabody Trust CO
- $1.18 Billion
- Q3 2024
A detailed history of Nixon Peabody Trust CO transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 97,165 shares of RNXT stock, worth $126,314. This represents 0.01% of its overall portfolio holdings.
Number of Shares
97,165
Previous 97,165
-0.0%
Holding current value
$126,314
Previous $109,000
6.42%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
16Shares Held
2.87MCall Options Held
0Put Options Held
0-
Bank Of Montreal Toronto, A6975KShares$1.27 Million0.0% of portfolio
-
Bank Of The West975KShares$1.27 Million0.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX315KShares$409,7490.05% of portfolio
-
Geode Capital Management, LLC Boston, MA233KShares$302,8180.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny82.4KShares$107,0580.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $11.8M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...